Aptalis Holdings | Evaluate

Scuttled IPOs cast pall on struggling biotech sector

Forest bids to dominate both ends of IBS market

April 10, 2014

Q1 M&A data underline strong sentiment in life science sector

February 18, 2014

Actavis enters the Forest and comes out a specialty pharma company

January 08, 2014

No float needed as Forest picks up Aptalis

January 03, 2014

Pharma business development news over Christmas

May 15, 2012

Ventrus' late stage pipeline shaping up

February 07, 2012

Merck’s new sleep drug has soporific effect on markets

January 13, 2011

Lilly in need of PEP talk after adcom rejection of Solpura

January 06, 2011

Event - Liprotamase approval could PEP up Lilly fortunes

December 03, 2010

Eurand deal could be a steal for Axcan

Load More